Cargando…
MON-277 Patient Health Questionnaire 9 (PHQ-9) and Barrat Impulsivity Scale (BIS-11); Tools to Identify Side Effects of Dopamine Agonist Treatment in Patients with Pituitary Adenomas
Background There is augmented concern for dopamine agonists (DA) related risk to mood and impulse control disorders (ICD) in patients (pts) with pituitary adenomas (PA). In this study, we analyzed prevalence using two validated self-assessment screening surveys; PHQ-9 and BIS-11. Methods A retrospec...
Autores principales: | Hinojosa-Amaya, José Miguel, Johnson, Nathaniel, Varlamov, Elena V, González-Torres, Christine, Yedinak, Christina G, McCartney, Shirley, Fleseriu, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208366/ http://dx.doi.org/10.1210/jendso/bvaa046.978 |
Ejemplares similares
-
MON-320 Inter-Rater Reliability of T2 MRI Intensity of Somatotroph Adenomas; Endocrinologists vs. Neuroradiologist Pilot Study
por: Varlamov, Elena V, et al.
Publicado: (2020) -
Functioning Pituitary Adenomas – Current Treatment Options and Emerging Medical Therapies
por: Varlamov, Elena V, et al.
Publicado: (2019) -
MON-308 Pituitary Magnetic Resonance Imaging in the Postoperative Follow-Up of Patients with Acromegaly, Less Is More!
por: Fernandes, Stuti, et al.
Publicado: (2020) -
Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2020) -
MON-LB081 Pituitary Adenomas: A Pan-genomic Classification
por: NEOU, Mario, et al.
Publicado: (2019)